McKesson Launches InspiroGene, a Dedicated Business to Guide and Support the Commercialization of Cell and Gene TherapiesBusiness Wire • 10/01/24
McKesson Corporation Announces Second Quarter Fiscal 2025 Earnings Release DateBusiness Wire • 09/23/24
Here's Why You Should Retain McKesson Stock in Your Portfolio NowZacks Investment Research • 09/19/24
McKesson (MCK) Rises Yet Lags Behind Market: Some Facts Worth KnowingZacks Investment Research • 09/12/24
McKesson Shares Fall Following Sale of Rexall, Well.ca to Birch HillZacks Investment Research • 09/06/24
S&P 500 Gains and Losses Today: McKesson Falls Amid Plans To Exit Canada BusinessesInvestopedia • 09/05/24
McKesson Corporation (MCK) Wells Fargo 2024 Healthcare Conference (Transcript)Seeking Alpha • 09/05/24
McKesson Corporation Announces Sale of Rexall and Well.ca Businesses to Birch Hill Equity PartnersBusiness Wire • 09/05/24
Wall Street Analysts See McKesson (MCK) as a Buy: Should You Invest?Zacks Investment Research • 08/28/24
MCK Stock's Uptrend Likely to Continue After Core Ventures AcquisitionZacks Investment Research • 08/27/24
Drug distributor McKesson to buy controlling stake in Core Ventures for about $2.5 blnReuters • 08/26/24
McKesson to acquire controlling stake in Core Ventures for $2.49 billion in cashMarket Watch • 08/26/24
McKesson Signs Agreement to Acquire Controlling Interest in Florida Cancer Specialists & Research Institute's Core VenturesBusiness Wire • 08/26/24